Avacta Group PLC (AVCT)

ORD 10P

Sell: 63.00p|Buy: 65.00p|Change: 0.50 (-0.78%)

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

CORRECT (Sep 01): hVIVO appoints Avacta Chair Shaun Chilton to board

(Correcting share price for September 1.)

(Alliance News) - hVIVO PLC on September 1 said it appointed Shaun Chilton to the board of directors as non-executive chair.

hVIVO is a London-based contract research organisation testing vaccines for infectious and respiratory diseases.

Chilton was previously chief executive officer of Clinigen Group PLC, a global pharmaceutical services firm.

He is currently non-executive chair of Wetherby, West Yorkshire-based life sciences company Avacta Group PLC and Kintiga Ltd, and is an independent supervisory board member at Product Life Group.

"Shaun brings a wealth of sector-relevant experience and we believe his expertise will support us as we continue to grow and diversify the group. As a board we look forward to working closely with Shaun to help deliver on the company's mission and execute on our strategy," said Interim Chair Elaine Sullivan.

Incoming Chair Chilton commented: "I am pleased to join the board of hVIVO, a company which I believe has excellent prospects as it continues to diversify its service offering while leading the global charge in delivering exceptional human challenge trial services to its clients."

Shares in hVIVO closed down flat at 9.90 pence each in London on September 1.

Its shares closed 8.9% lower at 9.00 pence each on Monday.

By Michael Hennessey, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.